To Evaluate the Influence of the A118G Polymorphism in the mu Opioid Receptor Gene (OPRM1) on Effects of GSK1521498 and Naltrexone on Physiological and Behavioural Markers of Brain Function in Healthy Social Drinkers
Clinical trial NCT01738867 · COMPLETED
Trial details
- NCT number
- NCT01738867
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-12
- Primary completion
- 2014-05-27
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.